Evidence map›Paper›PMID 34617629›Full record

ArticleJournal of medical virology2022

Measles outbreak, Montenegro January-July 2018: Lessons learned.

Boban Mugoša, Giancarlo Ceccarelli, Senad Begić, Danijela Vujošević, Zeljka Zekovic, Massimo Ciccozzi, Zoran Vratnica

Abstract read
In one paragraph

Article in Journal of medical virology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Boban MugošaInstitute of Public Health of Montenegro, Podgorica, Montenegro.
Giancarlo CeccarelliDepartment of Public Health and Infectious Diseases, University of Rome "Sapienza", Rome, Italy.ORCID 0000-0001-5921-3180
Senad BegićInstitute of Public Health of Montenegro, Podgorica, Montenegro.
Danijela VujoševićInstitute of Public Health of Montenegro, Podgorica, Montenegro.
Zeljka ZekovicInstitute of Public Health of Montenegro, Podgorica, Montenegro.
Massimo CiccozziUnit of Medical Statistics and Molecular Epidemiology, University of Biomedical Campus, Rome, Italy.ORCID 0000-0003-3866-9239
Zoran VratnicaInstitute of Public Health of Montenegro, Podgorica, Montenegro.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In 2017, the Regional Verification Commission for Measles and Rubella Elimination (RVC) of the World Health Organization confirmed that measles elimination was sustained in Montenegro, and the previous endemic transmission remained interrupted. However, the RVC was extremely concerned over the continuing low vaccination coverage reported for this country. In this study, we describe the most recent measles epidemic in Montenegro using the epidemiological data collected from January 1 to July 31, 2018. The outbreak is largely attributable to a dangerous accumulation of susceptible subjects across the country and represents a high-risk factor for re-establishing endemic transmission in the Balkan area. This study showed how a vaccine-preventable communicable disease outbreak can have a dramatic impact and severe consequences on regional public health system performance in terms of the sanitary spending point of view. A detailed update is provided on the epidemiological situation in this Central European area, not available until now.

Indexed as

Disease EradicationAdolescentAdultChildChild, PreschoolDisease OutbreaksFemaleHumansInfantLogistic ModelsMaleMeaslesMeasles VaccineMontenegroRisk FactorsVaccination CoverageMeasles VaccineBalkancommunicable diseaseepidemicEuropemeaslesMontenegrooutbreakvaccine

Identifiers

PMID34617629
PMCPMC9291602

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.